EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374 | +289.6% | 19,310 | +65.6% | 0.00% | – |
| Q2 2023 | $96 | +12.9% | 11,661 | 0.0% | 0.00% | – |
| Q1 2023 | $85 | -17.5% | 11,661 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $103 | -99.9% | 11,661 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $143,000 | +3.6% | 11,661 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $138,000 | -37.8% | 11,661 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $222,000 | -28.4% | 11,661 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $310,000 | -35.3% | 11,661 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $479,000 | -27.4% | 11,661 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $660,000 | +34.7% | 11,661 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $490,000 | -40.1% | 11,661 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $818,000 | +145.6% | 11,661 | -1.9% | 0.00% | +100.0% |
| Q3 2020 | $333,000 | -5.4% | 11,883 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $352,000 | – | 11,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |